Affordable Access

Publisher Website

The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: Report from a meeting of experts convened to discuss TBE in their region

Authors
Journal
Vaccine
0264-410X
Publisher
Elsevier
Publication Date
Volume
29
Issue
28
Identifiers
DOI: 10.1016/j.vaccine.2011.04.061
Keywords
  • Tick-Borne Encephalitis
  • Tbe
  • Flavivirus
Disciplines
  • Medicine

Abstract

Abstract Tick-borne encephalitis (TBE) is a potentially life-threatening disease in humans and is caused by a flavivirus spread by infected ticks (Ixodes ricinus and Ixodes persulcatus). TBE is endemic across much of Central and Eastern Europe and the incidence is increasing, with numbers estimated to be as many as 8755 cases per year. The reasons for this increase are multi-faceted and may involve improvements in diagnosis and reporting of TBE cases, increases in recreational activities in areas inhabited by infected ticks and changes in climatic conditions affecting tick habitats. Vaccination is the most effective method of preventing TBE; following a successful nationwide vaccination campaign in Austria, the annual number of TBE cases fell to about 10% of those reported in the pre-vaccination era. This report describes the findings of a group of leading experts from six Central and Eastern European countries who convened to discuss TBE in their region during the 28th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) Nice, France, 4–8 May 2010.

There are no comments yet on this publication. Be the first to share your thoughts.